HTTP/1.1 404 Object Not Found
Server: Microsoft-IIS/5.0
Date: Sat, 22 Nov 2008 07:20:51 GMT
X-Powered-By: ASP.NET
Connection: close
Content-Type: text/html
404 Object Not Found
|
2002-2003
Research Grants/Awards
2002
Gynecologic Cancer Foundation / Eli Lilly and Company
Award for the Outstanding Paper by a Fellow
or Resident
Important
Note: All candidates who qualify for this award based on the below criteria
will automatically be included in the evaluation process.
Eligibility
Candidates for this award must have performed the research
during residency in obstetrics and gynecology or during their fellowship
training in gynecologic oncology and also must be a trainee at the time
the abstract is submitted. The abstract must have been accepted by the
Program Committee for either oral or poster presentation. The candidate
must be the sole or first author of the manuscript. The work must be a
report of clinical or basic research. Manuscripts may not be a review
of work performed by others. Papers already published are not eligible
for consideration. A paper may be submitted for publication after the
abstract is sent to the Program Committee, but may not appear in print
prior to the SGO 34th Annual Meeting. American applicants must be enrolled
in an accredited U.S. residency program in obstetrics and gynecology or
an American Board of Obstetricians and Gynecologists approved fellowship
program in gynecologic oncology. Foreign applicants must be enrolled in
a similar program.
Selection Process
All Fellows – In- Training and Residents
should submit abstracts to the Program Committee in the usual fashion.
A completed GCF Award application must accompany the abstract. As soon
as the Program Committee has selected its program, all qualified abstracts
for this award will be submitted to the GCF Awards Committee for review.
ALL CANDIDATES WHO QUALIFY FOR THIS AWARD BASED ON ABOVE CRITERIA WILL
AUTOMATICALLY BE INCLUDED IN THE EVALUATION PROCESS. Each accepted
applicant must submit a complete manuscript within the time frame stipulated
by the Program Committee. Manuscripts will be distributed to the GCF Awards
Committee for review prior to the meeting and a scoring sheet will be
completed. The scoring will be based on study design, originality, scientific
merit, importance to the field and presentation. During the 2003 SGO Annual
Meeting, the GCF Awards Committee will meet and select the outstanding
paper.
Award
The
2003 GCF/Eli Lilly and Company Award for the Outstanding Paper by a Resident
or Fellow will be announced following the SGO 34th Annual Meeting and
the winner will receive $1,500.
 |
GCF
GRATEFULLY ACKNOWLEDGES
ELI LILLY AND COMPANY FOR THE
EDUCATIONAL GRANT PROVIDED
TO SUPPORT THIS AWARD |
|
